drugset / Trial / NCT02844660

Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers

NCT02844660 ↗

Completed 130 enrolled MiMedx Group, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

A Multicenter, Prospective, Randomized Controlled Comparative Parallel Study To determine the safety and effectiveness of EpiCord as compared to standard of care (SOC) therapy for the treatment of chronic, non-healing diabetic foot ulcers (DFUs)

Timeline

Start
2016-07
Primary completion
2018-07
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Subject EpiCord Unknown — —

Indications